FMC Posts $1.49 Q2 Loss Per Share, Deepening Red Ink
FMC is trading near its 52-week low of $9.945 (2.7% above the low) on elevated volume (1.9× avg).
Summary
FMC reported a Q2 loss of $1.49 per share, a sharp deterioration from the $281.3 million net loss in Q1. The company's Q2 adjusted EPS beat estimates, but it cut its full-year outlook. The result lands amid a heavy restructuring and debt refinancing push—the company recently closed a $1.2 billion note offering and secured a $400 million equity investment from Tessenderlo at $13.30 per share. With the stock trading near its 52-week low of $9.95, the loss raises urgent questions about whether the turnaround plan is gaining traction or burning through cash faster than expected. The next catalyst is the Q2 earnings call, where management must address the restructuring timeline and any updated guidance.
At the time of this announcement, FMC was trading at $10.21 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $9.95 to $42.77. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.